Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Synergy CHC Corp SNYR

Synergy CHC Corp. is a consumer healthcare and beauty company. The Company is a portfolio of consumer health care and beauty brands, including FOCUS factor, FLAT TUMMY CO, HAND MD, Sneaky Vaunt, THE QUEEN PEGASUS. FOCUS factor is a brain health supplement brand. FLAT TUMMY CO is a lifestyle brand, which helps women achieve their nutrition and weight management goals. HAND MD is a hand care brand to maintain clean, healthy and beautiful hands. THE QUEEN PEGASUS provides eyelash serum for longer and thicker looking natural lashes. Sneaky Vaunt offers flat tummy tea.


GREY:SNYR - Post by User

Post by stockfyon Jun 04, 2020 4:37am
171 Views
Post# 31110068

Online retailers, Covid, Synergy's (SNYR) adj. EBITDA $4.2m

Online retailers, Covid, Synergy's (SNYR) adj. EBITDA $4.2mSNYR is a pure online retailer, so the rush to online buying this quarter due to the stay-at-home orders does help SNYR, so adjusted EBITDA will reach or exceed $5 million this year.

Adjusted EBITDA was  $4.2 million in 2019, UP 110% compared to 2018: 

https://www.globenewswire.com/news-release/2020/04/29/2024687/0/en/Synergy-CHC-Corp-Announces-Fiscal-2019-Year-End-Results.html



So Enterprise Value-to-adjusted EBITDA currently is about 3 times and SNYR is dirt cheap at 15 cents.

The CEO is not idiot. This is why he owns 50% and Knight Therapeutics (GUD) owns another 19%.



<< Previous
Bullboard Posts
Next >>